Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

The Joint Corp.

JYNTNASDAQ
Healthcare
Medical - Care Facilities
$9.11
$0.00(0.00%)
U.S. Market opens in 1h 56m

The Joint Corp. Fundamental Analysis

The Joint Corp. (JYNT) shows moderate financial fundamentals with a PE ratio of -177.62, profit margin of -55.34%, and ROE of -3.70%. The company generates $0.0B in annual revenue with strong year-over-year growth of 10.47%.

Key Strengths

Cash Position21.57%
PEG Ratio-2.22
Current Ratio1.80

Areas of Concern

ROE-3.70%
Operating Margin1.51%
We analyze JYNT's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -6.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-6.5/100

We analyze JYNT's fundamental strength across five key dimensions:

Efficiency Score

Weak

JYNT struggles to generate sufficient returns from assets.

ROA > 10%
-1.15%

Valuation Score

Excellent

JYNT trades at attractive valuation levels.

PE < 25
-177.62
PEG Ratio < 2
-2.22

Growth Score

Excellent

JYNT delivers strong and consistent growth momentum.

Revenue Growth > 5%
10.47%
EPS Growth > 10%
13.64%

Financial Health Score

Excellent

JYNT maintains a strong and stable balance sheet.

Debt/Equity < 1
0.09
Current Ratio > 1
1.80

Profitability Score

Weak

JYNT struggles to sustain strong margins.

ROE > 15%
-369.54%
Net Margin ≥ 15%
-55.34%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is JYNT Expensive or Cheap?

P/E Ratio

JYNT trades at -177.62 times earnings. This suggests potential undervaluation.

-177.62

PEG Ratio

When adjusting for growth, JYNT's PEG of -2.22 indicates potential undervaluation.

-2.22

Price to Book

The market values The Joint Corp. at 6.25 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

6.25

EV/EBITDA

Enterprise value stands at -118.01 times EBITDA. This is generally considered low.

-118.01

How Well Does JYNT Make Money?

Net Profit Margin

For every $100 in sales, The Joint Corp. keeps $-55.34 as profit after all expenses.

-55.34%

Operating Margin

Core operations generate 1.51 in profit for every $100 in revenue, before interest and taxes.

1.51%

ROE

Management delivers $-3.70 in profit for every $100 of shareholder equity.

-3.70%

ROA

The Joint Corp. generates $-1.15 in profit for every $100 in assets, demonstrating efficient asset deployment.

-1.15%

Following the Money - Real Cash Generation

Operating Cash Flow

The Joint Corp. generates strong operating cash flow of $3.04M, reflecting robust business health.

$3.04M

Free Cash Flow

The Joint Corp. generates strong free cash flow of $1.62M, providing ample flexibility for dividends, buybacks, or growth.

$1.62M

FCF Per Share

Each share generates $0.11 in free cash annually.

$0.11

FCF Yield

JYNT converts 1.16% of its market value into free cash.

1.16%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-177.62

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-2.22

vs 25 benchmark

P/B Ratio

Price to book value ratio

6.25

vs 25 benchmark

P/S Ratio

Price to sales ratio

97.30

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.09

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.80

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.04

vs 25 benchmark

ROA

Return on assets percentage

-0.01

vs 25 benchmark

ROCE

Return on capital employed

0.06

vs 25 benchmark

How JYNT Stacks Against Its Sector Peers

MetricJYNT ValueSector AveragePerformance
P/E Ratio-177.6229.45 Better (Cheaper)
ROE-3.70%779.00% Weak
Net Margin-55.34%-24936.00% (disorted) Weak
Debt/Equity0.090.26 Strong (Low Leverage)
Current Ratio1.804.65 Neutral
ROA-1.15%-19344.00% (disorted) Weak

JYNT outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews The Joint Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-0.79%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-337.72%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

15.94%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ